Search filters

List of works by Katarzyna Gach-Janczak

A New Hybrid δ-Lactone Induces Apoptosis and Potentiates Anticancer Activity of Taxol in HL-60 Human Leukemia Cells

scientific article published on 25 March 2020

Anticancer properties of a new hybrid analog AD-013 combining a coumarin scaffold with an α-methylene-δ-lactone motif.

scientific article published on 21 September 2017

Biological activity of endomorphin and [Dmt1]endomorphin analogs with six-membered proline surrogates in position 2.

scientific article published on 3 May 2009

Cyclization in Opioid Peptides

scientific article published on June 1, 2013

Effect of 2′,6′-dimethyl-l-tyrosine (Dmt) on pharmacological activity of cyclic endomorphin-2 and morphiceptin analogs

scientific article published on 20 October 2011

Effect of potent endomorphin degradation blockers on analgesic and antidepressant-like responses in mice

scientific article published on 22 July 2011

Functional characterization of opioid receptor ligands by aequorin luminescence-based calcium assay

scientific article published on 23 February 2006

Identification of endomorphin-1 and endomorphin-2 binding sites in human mu-opioid receptor by antisense oligonucleotide strategy

scientific article

In vitro and in vivo activity of opioid cyclopeptide with mu/delta agonist profile biased toward β-arrestin

scientific article published on 20 April 2018

Involvement of α-methylene-γ- and δ-lactones in the suppression of multidrug resistance in MCF-7 cells

scientific article published on 10 January 2018

Kinetic studies of novel inhibitors of endomorphin degrading enzymes

scientific article

Molecular mechanisms of apoptosis induced by a novel synthetic quinolinone derivative in HL-60 human leukemia cells

scientific article published on 25 February 2020

Novel endomorphin analogues with antagonist activity at the mu-opioid receptor in the gastrointestinal tract

scientific article

Opioid antagonist-induced regulation of the mu-opioid receptor expression in MCF-7 breast cancer cell line

scientific article published on January 2009

Opioid-induced regulation of mu-opioid receptor gene expression in the MCF-7 breast cancer cell line

scientific article

Synthesis and Anticancer Properties of New 3-Methylidene-1-sulfonyl-2,3-dihydroquinolin-4(1H)-ones

scientific article published in 2022

Synthesis and activity of opioid peptidomimetics with β2- and β3-amino acids

scientific article published on 3 August 2017

Synthesis and biological activity of endomorphin-2 analogs incorporating piperidine-2-, 3- or 4-carboxylic acids instead of proline in position 2.

scientific article published on 13 June 2008

Synthesis and biological evaluation of novel peripherally active morphiceptin analogs

scientific article published on 29 April 2010

Synthesis, Selected Transformations, and Biological Activity of Alkoxy Analogues of Lepidilines A and C

scientific article published on 21 September 2020

Thapsigargin-From Traditional Medicine to Anticancer Drug

scientific article published on 22 December 2020

The Gliopeptide ODN, a Ligand for the Benzodiazepine Site of GABA<sub>A</sub> Receptors, Boosts Functional Recovery after Stroke

scientific article published on 01 July 2021

The influence of opioids on urokinase plasminogen activator on protein and mRNA level in MCF-7 breast cancer cell line

scientific article

The mu-opioid receptor-selective peptide antagonists, antanal-1 and antanal-2, produce anticonvulsant effects in mice

scientific article published on 11 August 2012

The novel endomorphin degradation blockers Tyr-Pro-DClPhe-Phe-NH (EMDB-1) and Tyr-Pro-Ala-NH (EMDB-2) prolong endomorphin-2 action in rat ileum in vitro

scientific article published on 23 April 2010

[D-1-Nal4]endomorphin-2 is a potent micro-opioid receptor antagonist in the aequorin luminescence-based calcium assay

scientific article published on 21 March 2006